Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Tuberculosis (Edinburgh, Scotland)|March 1, 2006
Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunizationZhou Xing, Brian D LichtyImmunotherapy|November 6, 2013
Evolution of oncolytic viruses: novel strategies for cancer treatmentMatthew J Atherton, Brian D LichtyHuman Gene Therapy|March 30, 2011
Strategies to enhance viral penetration of solid tumorsElspeth Smith, Jessica Breznik, Brian D LichtyJournal of Virological Methods|August 12, 2008
Using G-deleted vesicular stomatitis virus to probe the innate anti-viral responseFrances Lai, Natasha Kazdhan, Brian D LichtyCytokine & Growth Factor Reviews|March 16, 2010
Combining oncolytic virotherapy and tumour vaccinationByram W Bridle, Stephen Hanson, Brian D LichtyMethods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic VaccinationJonathan G Pol, Byram W Bridle, Brian D LichtyJournal for Immunotherapy of Cancer|March 5, 2022
Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regressionAdam Nelson, Simon Gebremeskel, Brian D Lichty, et al.Current Opinion in Molecular Therapeutics|January 27, 2009
Diplomatic immunity: turning a foe into an allyKelley A Parato, Brian D Lichty, John C BellEbiomedicine|July 14, 2016
Oncolytic Viruses: Therapeutics With an Identity CrisisCaroline J Breitbach, Brian D Lichty, John C BellThe Journal of General Virology|October 13, 2006
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motifBrian D Lichty, Heidi McBride, Stephen Hanson, et al.Pageof 8